Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study Sandro da Costa Ferreira; Rogério Serafim Parra; Ligia Yukie Sassaki; José Miguel Luz Parente; Munique Kurtz de Mello; Liliana Andrade Chebli; Rafael Luís Luporini; Antonio José Tiburcio Alves Junior; Fernando Jorge Firmino Nóbrega; Bruno César da Silva; Eron Fábio Miranda; Abel Botelho Quaresma; Guilherme Mattioli Nicollelli; Rodrigo Galhardi Gasparini; Renata de Medeiros Dutra; Juarez Roberto de Oliveira Vasconcelos; Katia da Conceição da Silva; Daniéla Oliveira Magro; Marcello Rabello Imbrizi; Cristiane Kibune Nagasako; Omar Féres; Luiz Ernesto de Almeida Troncon; Paulo Gustavo Kotze; Júlio Maria Fonseca Chebli;

Combination of granulocyte¿monocyte apheresis and ustekinumab: Multicentre and retrospective study Iago Rodríguez-Lago; Claudia Herrera-deGuise; Maia Boscá-Watts; Cristina Rodríguez; Eduardo Leo-Carnerero; María Calvo Íñiguez; Fiorella Cañete; Silvia Chacón; Camila Cuarán; Ainara Elorza; Elena Guerra-del-Río; Eva Iglesias; Damián Sánchez; Manuel Barreiro-de Acosta; Daniel Ginard; José Luis Cabriada;

Combination of granulocyte¿monocyte apheresis and tofacitinib: Multicentre and retrospective study Iago Rodríguez-Lago; Fiorella Cañete; Elena Guerra-del-Río; Claudia Herrera-deGuise; Eva Iglesias; Eduardo Leo; Yamile Zabana; Manuel Barreiro-de Acosta; Daniel Ginard; José Luis Cabriada;